TP53 and serous adenocarcinoma: Moreover, a strong association was observed in TP53-mutant serous carcinoma (HR = 2.1; 95% CI = 1.39–3.18; p = 0.00033) (Figure 2B) but not in TP53-wild-type serous carcinoma (HR = 0.16; 95% CI = 0.03–0.79; p = 0.01) (Figure 2C) (Supplementary Figure 1).